Steve Schonfeld’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Buy
+15,293
New +$93.6K ﹤0.01% 2225
2026
Q1
Sell
-35,220
Closed -$342K 2592
2025
Q4
$342K Buy
+35,220
New +$299K ﹤0.01% 1529
2025
Q3
Sell
-234,806
Closed -$2.18M 2512
2025
Q2
$2.18M Sell
234,806
-223,866
-49% -$1.95M 0.01% 930
2025
Q1
$4.47M Buy
458,672
+295,372
+181% +$3.66M 0.03% 562
2024
Q4
$1.98M Sell
163,300
-408,927
-71% -$4.97M 0.01% 839
2024
Q3
$6.27M Sell
572,227
-409,008
-42% -$4.15M 0.04% 458
2024
Q2
$8.83M Buy
981,235
+822,944
+520% +$5.74M 0.06% 385
2024
Q1
$1.29M Buy
158,291
+115,897
+273% +$950K 0.01% 1133
2023
Q4
$357K Buy
+42,394
New +$492K ﹤0.01% 1380

Other funds holding REPL

Steve Schonfeld's REPL Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Replimune Group (REPL) in Q2 2026: 15,293 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #2225 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in REPL as recently as Q4 2025.

Steve Schonfeld first reported a position in REPL in Q4 2023 and has held it in 9 quarters since. The position peaked at $8.83M in Q2 2024. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Steve Schonfeld held 15,293 shares of Replimune Group worth $169K as of Q2 2026.
  • Replimune Group was a new Steve Schonfeld position in Q2 2026.
  • Replimune Group made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2225 holding.
  • Steve Schonfeld first reported a position in Replimune Group in Q4 2023 and has held it in 9 quarters since.
  • Steve Schonfeld's Replimune Group position peaked at $8.83M in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.